Healthcare -
Biotechnology - NASDAQ - US
$ 6.385
3.15 %
$ 286 M
Market Cap
-11.82
P/E
YMAB - DEPRECIATION & AMORTIZATION
Depreciation & Amortization YMAB - Y-mAbs Therapeutics, Inc.
735 K
LAST VALUE
-3.05%
2 YEAR CAGR
90.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR